Skip to content
Science

Kolmar BNH Expedites European Market Expansion with its Technology-Driven HemoHIM G

Kolmar BNH 2 mins read
SEOUL, South Korea--BUSINESS WIRE--

Kolmar BNH (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is accelerating its expansion efforts into the Southeast Asian and European markets with HemoHIM G, a product designed for the global arena.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724688710/en/

HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)

HemoHIM G, manufactured by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)

HemoHIM G (Global) is the international version of ‘HemoHIM’, Korea’s first individually-approved immune-boosting health supplement developed by Kolmar BNH over an eight-year period. The formulation has been tailored to comply with the food regulations of various countries, with adjustments made to raw materials and ingredient ratios. The product features angelica sinensis, ligusticum chuanxiong, paeonia lactiflora, all selected through rigorous quality control processes. Enhanced taste and aroma also make HemoHIM G more appealing to a broader audience.

In April, Kolmar BNH published a study on HemoHIM G in the SCIE-ranked journal Toxicological Research, demonstrating its safety. Conducted according to OECD guidelines, the study holds significance not only in facilitating safety approvals in other countries but also in reinforcing intellectual property rights with reliable results.

HemoHIM, distributed by Atomy, is a technologically-advanced product of Kolmar BNH. The main ingredient, HemoHIM extract complex of angelica gigas, etc., was developed in collaboration with the Korea Atomic Energy Research Institute. Currently, it is available in 19 countries, including Australia, the United States, Thailand, Central Asia, and South America.

Kolmar BNH continues its efforts in research and development to enhance HemoHIM’s global competitiveness including new functionalities, through investing about 4% of its annual revenues to R&D. In June, the company published a study showing that the main ingredient of HemoHIM (HemoHIM extract complex of angelica gigas, etc.), has antioxidant and anti-fatigue effects, which are newly discovered. This study was featured in the June issue of the ‘Journal of Medicinal Food,’ an SCIE-level international journal.

Leveraging the competitive edge of HemoHIM G, the company plans to speed up exports to European countries, including Turkey, Italy, and Belgium.

An official from Kolmar BNH said, “HemoHIM is Korea’s one of the best-selling health supplements, with cumulative sales of KRW 200 billion over the past nine years since 2014. We aim to build on our success in Korea and accelerate our expansion into the European market.”


Contact details:

Kolmar BNH
Jang Woo Lee
Jay.lee@kolmar.co.kr

Media

More from this category

  • Engineering, Science
  • 05/12/2024
  • 09:45
UNSW Sydney

‘A million times better’: how frequency combs could provide a quantum leap for Satellite Network Synchronisation

Engineers at UNSW say exciting new developments in the way optical clocks can be synchronised has the potential to radically change global positioning systems – as well as fundamental cosmological theories. Satellites in space need to synchronise very precisely in order for communications to proceed efficiently. Synchronisation also allows the time taken for signals to be sent across a network to be calculated, which then allows positioning to be determined. Currently global positioning is accurate in most circumstances to within about 1 metre, but if the timing of signals is miscalculated by just 1 nanosecond the error would be a…

  • Energy, Science
  • 04/12/2024
  • 11:46
Charles Darwin University

CDU EXPERT: Ouch! Why do everyday objects keep zapping me?

4 DECEMBER, 2024 Who: AI expert and adjunct Associate Professor at Charles Darwin University in the Faculty of Science and Technology, and Associate Professor at Australian Catholic University Associate Professor Niusha Shafiabady. Associate Professor Shafiabady is an internationally recognised expert and developer of AI data analysis platform Ai-Labz. Topics: The discovery of static electricity, and how it works. How to avoid being zapped by static electricity. Contact details: Call +61 8 8946 6721 or email media@cdu.edu.au to arrange an interview. Quotes attributable to Associate Professor Shafiabady: “Static charge is inconvenient, but it is not dangerous except in places where we…

  • Energy, Science
  • 04/12/2024
  • 07:33
UNSW Sydney

Proton batteries: an innovative option for the future of energy storage

An eco-friendly, high-performance organic battery is being developed by scientists at UNSW Sydney. A team of scientists atUNSW Chemistryhave successfully developed an organic material that is able to store protons –and they have used it to create a rechargeable proton battery in the lab. By leveraging hydrogen ions – protons – instead of traditional lithium, these batteries hold promise for addressing some of the critical challenges in modern energy storage, including resource scarcity, environmental impact, safety and cost. The latest findings, recently published in the journalAngewandte Chemie, highlight the battery’s ability to store energy quickly, last longer, and perform well…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.